In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Cephalon to co-promote Novartis CNS drugs in UK; terminated

Executive Summary

Cephalon's (CNS drugs) UK subsidiary licensed exclusive co-promotion rights to four Novartis central nervous system drugs. Cephalon will pay $40mm in a series of installments through 2002.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Includes Contract
    • Co-Promotion
    • Product or Technology Swap
    • Reverse Licensing

Related Companies

UsernamePublicRestriction

Register